The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
isradipine · Powder
3 marketed package NDCs · 3 active manufacturers
Most dispensed: 2.5 mg · Capsule · #100 capsules/bottle · 5 mg · Capsule · #100 capsules/bottle
What changed in the last 90 days
Every detected change for isradipine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- IsradipineAug 19, 2026Price upNADAC $1.61198 → $1.65965 per unit (+2.96%)
- IsradipineAug 19, 2026Price downNADAC $1.40622 → $1.15892 per unit (-17.59%)
- IsradipineAug 19, 2026Price upNADAC $1.61198 → $1.65965 per unit (+2.96%)
- IsradipineAug 19, 2026Price downNADAC $1.40622 → $1.15892 per unit (-17.59%)
- IsradipineJul 22, 2026Price downNADAC $1.64719 → $1.61198 per unit (-2.14%)
- IsradipineJul 22, 2026Price downNADAC $1.50055 → $1.40622 per unit (-6.29%)
- IsradipineJul 22, 2026Price downNADAC $1.64719 → $1.61198 per unit (-2.14%)
- IsradipineJul 22, 2026Price downNADAC $1.50055 → $1.40622 per unit (-6.29%)
Same drug class
Other molecules FDA puts in Dihydropyridine Calcium Channel Blocker, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- aamlodipine and olmesartan medoxomil· 1 maker
- amlodipine besylate and atorvastatin calcium· 1 maker
- amlodipine besylate and valsartan· 1 maker
- amlodipine valsartan and hydrochlorothiazide· 1 maker
- amlodipine,valsartan and hydrochlorothiazide· 1 maker
- clevipidine· 1 maker
- felodipine extended-release tablets· 1 maker
- nicardipine· 1 maker
- olmesartan medoxomil amlodipine and hydrochlorothiazide· 1 maker
- olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide· 1 maker
- olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide· 1 maker
- telmisartan, amlodipine and indapamide· 1 maker
Common questions
- Is Isradipine in shortage right now?
- No. FDA does not currently list Isradipine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Isradipine?
- 6 companies have marketed Isradipine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Isradipine cost?
- The typical pharmacy pays about $1.41 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.